๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

โœ Scribed by R. A. Joss; R. L. Galeazzi; K. W. Brunner


Publisher
Springer
Year
1983
Tongue
English
Weight
580 KB
Volume
25
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Tropisetron in the prevention of nausea
โœ Benoit, Yves ;Hulstaert, Frank ;Vermylen, Christiane ;Sariban, Eric ;Hoyoux, Cla ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 649 KB

## Abstract Tropisetron (Navobanยฎ, Sandoz Pharma Ltd., Basel, Switzerland), a selective antagonist of the serotonin receptor (5โ€HT3) dosed onceโ€daily at 0.2 mg/kg (with a maximum of 5 mg daily), was evaluated in the prevention of chemotherapyโ€induced nausea and vomiting in 131 children with a media

High versus low dose granisetron, a sele
โœ H. C. Falkson; C. I. Falkson; G. Falkson ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 173 KB

Fifty six patients, with histologically confirmed cancer, who received highly emetogenic chemotherapy, were entered on a randomized double blind, low versus high dose, study of granisetron, a 5HT3 receptor antagonist. A single dose of intravenous granisetron protected the majority of patients from n

Letter to the editor: Tropisetron in the
โœ Berberoglu, Semha ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 10 KB ๐Ÿ‘ 3 views

Tropisetron in the Prevention of Nausea and Vomiting in 131 Children Receiving Cytotoxic Chemotherapy I have read with interest the report by Benoit et al. [1] were two infants. I agree with the authors that the efficacy and safety data was similar to those reported for older concerning the efficacy